BICDL1
BICD family-like cargo adapter 1
Also known as: BICDR-1, BICL1_HUMAN, CCDC64, FLJ26450
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZP65
- Gene
- BICDL1
- Ensembl
- ENSG00000135127
- Chromosome
- 12
- Canonical length
- 573 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
Predicted to enable dynactin binding activity and small GTPase binding activity. Predicted to be involved in Golgi to secretory granule transport; neuron projection development; and vesicle transport along microtubule. Predicted to be located in centrosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
573 residues, UniProt reviewed canonical sequence.
>Q6ZP65|BICDL1
1 MSAFCLGLVG RASAPAEPDS ACCMELPAAA GDAVRSPAAA AALIFPGGSG ELELALEEEL
61 ALLAAGERPS DPGEHPQAEP GSLAEGAGPQ PPPSQDPELL SVIRQKEKDL VLAARLGKAL
121 LERNQDMSRQ YEQMHKELTD KLEHLEQEKH ELRRRFENRE GEWEGRVSEL ESDVKQLQDE
181 LERQQIHLRE ADREKSRAVQ ELSEQNQRLL DQLSRASEVE RQLSMQVHAL REDFREKNSS
241 TNQHIIRLES LQAEIKMLSD RKRELEHRLS ATLEENDLLQ GTVEELQDRV LILERQGHDK
301 DLQLHQSQLE LQEVRLSCRQ LQVKVEELTE ERSLQSSAAT STSLLSEIEQ SMEAEELEQE
361 REQLRLQLWE AYCQVRYLCS HLRGNDSADS AVSTDSSMDE SSETSSAKDV PAGSLRTALN
421 ELKRLIQSIV DGMEPTVTLL SVEMTALKEE RDRLRVTSED KEPKEQLQKA IRDRDEAIAK
481 KNAVELELAK CRMDMMSLNS QLLDAIQQKL NLSQQLEAWQ DDMHRVIDRQ LMDTHLKERS
541 QPAAALCRGH SAGRGDEPSI AEGKRLFSFF RKILocalizationUniProt · AlphaFold · HPA
Whether an antibody against BICDL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 113 nTPM
Expression across tissuesHPA
Tissue
- kidney: 113 nTPM
- pituitary gland: 64 nTPM
- skin: 50 nTPM
- retina: 40 nTPM
- cerebellum: 32 nTPM
- esophagus: 29 nTPM
Single-cell type
- loop of henle epithelial cells: 564 nCPM
- cone photoreceptor cells: 544 nCPM
- rod photoreceptor cells: 532 nCPM
- somatotrophs: 468 nCPM
- proximal tubule cells: 404 nCPM
- distal convoluted tubule cells: 400 nCPM
Immune cell
- memory CD4 T-cell: 1.1 nTPM
- gdT-cell: 1 nTPM
- memory CD8 T-cell: 0.9 nTPM
- naive CD4 T-cell: 0.8 nTPM
- naive CD8 T-cell: 0.7 nTPM
- MAIT T-cell: 0.4 nTPM
Brain region
- cerebral cortex: 31 nTPM
- hypothalamus: 28 nTPM
- hippocampal formation: 22 nTPM
- amygdala: 22 nTPM
- basal ganglia: 21 nTPM
- thalamus: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.95
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- Golgi to secretory granule transport
- neuron projection development
- vesicle transport along microtubule
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BICDL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BICDL1 as an antibody target. Whether an autoantibody or antibody against BICDL1 could matter depends on whether native BICDL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BICDL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BICDL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...